Stock TEVJF TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Teva Pharmaceutical Industries Limited Other OTC

Equities

TEVJF

IL0006290147

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Teva Pharmaceutical Industries 'Well-Positioned' for Further Growth, UBS Says
MT
Global markets live: Tesco, Adobe, Tyson Foods, GameStop, Teva...
Our Logo
Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym
MT
Transcript : Teva Pharmaceutical Industries Limited Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 08:00 AM
Barclays Adjusts Price Target on Teva Pharmaceutical Industries to $21 From $20, Maintains Overweight Rating
MT
Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
BU
Teva Pharmaceuticals - New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY Extended-Release Injectable Suspension from Invega Sustenna
AQ
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
BU
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
BU
Teva Pharmaceutical Gains FDA Approval for Daily Huntington's Disease Pill
MT
Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)
BU
Teva Pharmaceutical Industries Limited Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24?48 mg/day)
CI
Teva and Alvotech Announce SIMLANDI Injection Now Available in the U.S.
AQ
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
BU
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
AQ
Teva Pharmaceutical Industries Limited and Alvotech Announce SIMLANDI® Injection Now Available in the U.S
CI
Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing
MT
New EVP, Teva Global Operations appointed
AQ
Teva Pharmaceutical Industries Insider Sold Shares Worth $254,807, According to a Recent SEC Filing
MT
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TEVA Stock
  4. TEVJF Stock
  5. News Teva Pharmaceutical Industries Limited